Response to an extra dose of hepatitis B vaccine and specific antibody persistence in non-responders to primary immunization

Scand J Gastroenterol. 1995 Jun;30(6):601-3. doi: 10.3109/00365529509089796.

Abstract

Background: In a campaign to vaccinate health care workers, a three-dose schedule (0, 1, and 6 months) and a four-dose schedule (0, 1, 2, and 14 months) with hepatitis B (HB) vaccine were used. After primary immunization 26 subjects vaccinated with the 3-dose schedule and 4 subjects vaccinated with the 4-dose schedule had undetectable anti-HBs titres.

Methods: All these 30 non-responders received an extra dose of the same vaccine 2 months after primary immunization and a booster dose with a yeast-derived vaccine 6 years later. Anti-HBs levels were evaluated 1 month after the extra dose and after the booster dose.

Results: One month after the extra dose 26.9% (7 of 26) of the subjects vaccinated with the 3-dose schedule became positive for anti-HBs. Six years later only two of these subjects had detectable anti-HBs. After the booster dose the seven subjects who responded to the extra dose showed an anamnestic type of response, and five additional subjects became positive for anti-HBs. Responders to the extra dose were significantly younger than the non-responders. In the four-dose group only one subject responded to the extra dose, and that subject maintained protective anti-HBs.

Conclusion: About 25% of non-responders to primary HB vaccination could benefit from an extra dose, and these subjects show an anamnestic type of response to HBs antigen even after 6 years. This response seems to be influenced by age.

MeSH terms

  • Adult
  • Female
  • Health Personnel
  • Hepatitis B / prevention & control
  • Hepatitis B Antibodies / analysis*
  • Hepatitis B Antibodies / biosynthesis
  • Hepatitis B Vaccines / administration & dosage*
  • Hepatitis B Vaccines / immunology*
  • Humans
  • Immunization Schedule
  • Immunization, Secondary*
  • Male
  • Middle Aged
  • Radioimmunoassay
  • Regression Analysis
  • Vaccination*

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Vaccines